Literature DB >> 24745683

Neuropsychological features of adult mastocytosis.

Daniela S Moura1, Sophie Georgin-Lavialle2, Raphaël Gaillard3, Olivier Hermine4.   

Abstract

In approximately one-third of cases, patients with mastocytosis can display various disabling general and neuropsychological symptoms. General signs may have a major impact on quality of life. Neurologic symptoms are less frequent. In a majority of cases, the pathophysiology of these symptoms is not known but could be linked to tissular mast cell infiltration, mast cell mediator release, or both. Treatments aiming at reducing mast cell number and/or stabilizating mast cells may be useful. Preliminary results suggest that treatment with kinase inhibitors may improve symptoms of depression and cognitive impairment.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anxiety; Cognitive impairment; Depression; Headache; Kit; Mast cell; Mastocytosis

Mesh:

Substances:

Year:  2014        PMID: 24745683     DOI: 10.1016/j.iac.2014.02.001

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  12 in total

Review 1.  Recent advances in our understanding of mast cell activation - or should it be mast cell mediator disorders?

Authors:  Theoharis C Theoharides; Irene Tsilioni; Huali Ren
Journal:  Expert Rev Clin Immunol       Date:  2019-04-22       Impact factor: 4.473

Review 2.  Systemic Mastocytosis: The Difficult Patient with a Rare Disease. Case Presentation and Brief Review.

Authors:  Daniel H Desmond; Mark G Carmichael
Journal:  Hawaii J Med Public Health       Date:  2018-02

3.  Mast cells' involvement in inflammation pathways linked to depression: evidence in mastocytosis.

Authors:  S Georgin-Lavialle; D S Moura; A Salvador; J-C Chauvet-Gelinier; J-M Launay; G Damaj; F Côté; E Soucié; M-O Chandesris; S Barète; C Grandpeix-Guyodo; C Bachmeyer; M-A Alyanakian; A Aouba; O Lortholary; P Dubreuil; J-R Teyssier; B Trojak; E Haffen; P Vandel; B Bonin; O Hermine; R Gaillard
Journal:  Mol Psychiatry       Date:  2016-01-26       Impact factor: 15.992

Review 4.  Brain "fog," inflammation and obesity: key aspects of neuropsychiatric disorders improved by luteolin.

Authors:  Theoharis C Theoharides; Julia M Stewart; Erifili Hatziagelaki; Gerasimos Kolaitis
Journal:  Front Neurosci       Date:  2015-07-03       Impact factor: 4.677

5.  Activated brain mast cells contribute to postoperative cognitive dysfunction by evoking microglia activation and neuronal apoptosis.

Authors:  Xiang Zhang; Hongquan Dong; Nana Li; Susu Zhang; Jie Sun; Shu Zhang; Yanning Qian
Journal:  J Neuroinflammation       Date:  2016-05-31       Impact factor: 8.322

Review 6.  Advances in the understanding and clinical management of mastocytosis and clonal mast cell activation syndromes.

Authors:  David González-de-Olano; Almudena Matito; Alberto Orfao; Luis Escribano
Journal:  F1000Res       Date:  2016-11-14

Review 7.  Targeted Treatment Options in Mastocytosis.

Authors:  Mélanie Vaes; Fleur Samantha Benghiat; Olivier Hermine
Journal:  Front Med (Lausanne)       Date:  2017-07-20

8.  Oral sensitization to whey proteins induces age- and sex-dependent behavioral abnormality and neuroinflammatory responses in a mouse model of food allergy: a potential role of mast cells.

Authors:  Danielle L Germundson; Nicholas A Smith; Lane P Vendsel; Andrea V Kelsch; Colin K Combs; Kumi Nagamoto-Combs
Journal:  J Neuroinflammation       Date:  2018-04-23       Impact factor: 8.322

9.  Mastocytosis patients' cognitive dysfunctions correlate with the presence of spindle-shaped mast cells in bone marrow.

Authors:  Natalia Spolak-Bobryk; Jan Romantowski; Hanna Kujawska-Danecka; Marek Niedoszytko
Journal:  Clin Transl Allergy       Date:  2022-01-11       Impact factor: 5.871

10.  Mast Cell Deficiency Protects Mice from Surgery-Induced Neuroinflammation.

Authors:  Xiang Zhang; Hongquan Dong; Fei Wang; Jun Zhang
Journal:  Mediators Inflamm       Date:  2020-08-01       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.